Jordan Feyko is a Vice President at Biospring Partners. Jordan leads Biospring's investment efforts in outsourced clinical trial services. Prior to Biospring, Jordan spent several years on the investment team at Health Velocity Capital, a healthcare-focused growth equity firm. During his time at Health Velocity, Jordan worked on growth investments in healthcare software and services business as well as supporting value creation efforts across the fund's portfolio.
Jordan comes primarily from an investing background, having previously worked at Francisco Partners, where he focused on growth and majority buyout transactions across the healthcare and technology sectors. Prior to Francisco Partners, he worked at Goldman Sachs in their Alternative Investment and Manager Selection (AIMS) group, focused on private equity investments. Jordan also spent time advising a large life sciences company as a Consultant at Bain & Company.
Jordan graduated from Harvard University with a B.A. in Applied Mathematics and Economics and completed his M.B.A at the Stanford University Graduate School of Business.
